|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Angiogenesis Research Center and Section of Cardiology, Dartmouth-Hitchcock Medical Center and Dartmouth Medical School, Lebanon, New Hampshire 03756; and 2 Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215
Syndecan-4 is one of the principal
heparan sulfate-carrying proteins on the cell surface. Unlike other
members of syndecan family, syndecan-4 mediates
phosphatidylinositol 4,5-bisphosphate 2 (PIP2)-dependent
PKC-
activation, and overexpression of syndecan-4 in vitro results
in enhanced FGF2 signaling. The present study was designed to test the
functional effect of increased syndecan-4 expression in endothelial
cells in transgenic mice. Several transgenic mice lines expressing
syndecan-4 cDNA under control of human endothelial nitric oxide (NO)
synthase (eNOS) promoter were generated. Exogenous syndecan-4 was
mainly expressed in the heart, brain, and lungs. In particular, the
heart demonstrated the greatest increase in the ratio of
transgenic-to-native syndecan-4 gene expression. Vessels from the
eNOS-syndecan-4 mice demonstrated more pronounced vasodilation to FGF2
but not to VEGF-A165, sodium nitroprusside, and A 23187 compared with wild-type mice. To elucidate the mechanism of this
effect, we measured NO release from primary cardiac endothelial cells
isolated from transgenic or wild-type adult mice. Cells from the
eNOS-syndecan-4 transgenic mice had a significant increase in FGF2- and
VEGF-A165-induced NO release compared with endothelial cells from the wild-type mice. However, the absolute magnitude of this
increase was higher for FGF2 than VEGF-A165. In conclusion, enhanced syndecan-4 expression in mouse cardiac endothelial cells results in preferential augmentation of FGF2 but not
VEGF-A165-induced NO release.
sodium nitroprusside; angiogenesis; heparan sulfate; nitric oxide; vascular endothelial growth factor
This article has been cited by other articles:
![]() |
M. Boodhwani, P. Voisine, M. Ruel, N. R. Sodha, J. Feng, S.-H. Xu, C. Bianchi, and F. W. Sellke Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 645 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Koh, R. D. Mahan, and G. E. Davis Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling J. Cell Sci., April 1, 2008; 121(7): 989 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Lanahan, T. W. Chittenden, E. Mulvihill, K. Smith, S. Schwartz, and M. Simons Synectin-dependent gene expression in endothelial cells Physiol Genomics, November 21, 2006; 27(3): 380 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tkachenko, J. M. Rhodes, and M. Simons Syndecans: New Kids on the Signaling Block Circ. Res., March 18, 2005; 96(5): 488 - 500. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |